BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6297254)

  • 1. Enhancement of concomitant immunity after radiation therapy and immunotherapy in a syngeneic murine tumour system.
    Deneufbourg JM
    Acta Radiol Oncol; 1982; 21(5):345-8. PubMed ID: 6297254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma.
    Suit HD; Sedlacek R; Wagner M; Orsi L; Silobrcic V; Rothman KJ
    Cancer Res; 1976 Apr; 36(4):1305-14. PubMed ID: 1260756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies with a spontaneous mouse tumor. I. Growth in normal mice and response to Corynebacterium parvum.
    Woodruff MF; Whitehead VL; Speedy G
    Br J Cancer; 1978 Mar; 37(3):345-55. PubMed ID: 638014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive correlation between the levels of natural killer cells and the in vivo resistance to syngeneic tumor transplants as influenced by various routes of administration of Corynebacterium parvum bacteria.
    Ojo E
    Cell Immunol; 1979 Jun; 45(1):182-7. PubMed ID: 455483
    [No Abstract]   [Full Text] [Related]  

  • 5. Antitumor activity of Corynebacterium parvum.
    Milas L; Scott MT
    Adv Cancer Res; 1978; 26():257-306. PubMed ID: 343523
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings: Therapy of methyl cholanthrene induced CBA mouse tumours with Corynebacterium parvum and irradiated tumour cells.
    Bomford R
    Br J Cancer; 1975 Aug; 32(2):241. PubMed ID: 1212356
    [No Abstract]   [Full Text] [Related]  

  • 7. Local control and disease-free survival after treatment of a squamous cell carcinoma by Corynebacterium parvum and local irradiation.
    Suit HD; Sedlacek R; Silobrcic V
    Cancer Res; 1977 Nov; 37(11):3869-75. PubMed ID: 908026
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of transplanted methylcholanthrene induced fibrosarcomata and Corynebacterium parvum on the immune response of CBA and A-HeJ mice to thymus dependent and independent antigens.
    James K; Ghaffar A; Milne I
    Br J Cancer; 1974 Jan; 29(1):11-20. PubMed ID: 4820942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active specific immunotherapy of mouse methylcholanthrene induced tumours with Corynebacterium parvum and irradiated tumour cells.
    Bomford R
    Br J Cancer; 1975 Nov; 32(5):551-7. PubMed ID: 1082344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of immunological and anti-tumour effects of orally administered Corynebacterium papvum in mice.
    Sadler TE; Castro JE
    Br J Cancer; 1975 Mar; 31(3):359-63. PubMed ID: 1156520
    [No Abstract]   [Full Text] [Related]  

  • 11. Surgery plus Corynebacterium parvum immunotherapy for Lewis lung carcinoma in mice.
    Karrer K; Rella W; Goldin A
    Eur J Cancer (1965); 1979 Jun; 15(6):867-73. PubMed ID: 499275
    [No Abstract]   [Full Text] [Related]  

  • 12. An analysis of the factors allowing promotion (rather than inhibition) of tumour growth by Corynebacterium parvum.
    Bomford R
    Int J Cancer; 1977 May; 19(5):673-9. PubMed ID: 863546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological effects of Corynebacterium parvum. 3. Amplification of resistance and impairment of active immunity to murine tumours.
    Smith SE; Scott MT
    Br J Cancer; 1972 Oct; 26(5):361-7. PubMed ID: 4343677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of immunostimulation by Corynebacterium parvum on evolution and metastatic dissemination of Lewis's tumor in mouse C57BL/6 mice].
    Pot-Deprun J; Chouroulinkov I
    C R Acad Hebd Seances Acad Sci D; 1975 Feb; 280(5):685-8. PubMed ID: 809167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Corynebacteria--stimulators of antitumor resistance].
    Zatula DG; Zaval'niuk AK; Tofan AV
    Eksp Onkol; 1984; 6(6):12-8. PubMed ID: 6396064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour metastasis in mice with reduced immune reactivity. IV. Restoration of relative resistance to metastasis formation in thymectomized sub-lethally irradiated mice by spleen cells.
    Suurküla M; Boeryd B
    Pathol Eur; 1975; 10(4):299-305. PubMed ID: 1208121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity to transplantable nitrosourea-induced neurogenic tumors. I. Potentiation of tumor immunity with Corynebacterium parvum.
    Cravioto HM; DeBernardo E; Hochwald GM; Thorbecke JG
    J Neuropathol Exp Neurol; 1981 Sep; 40(5):526-36. PubMed ID: 7276992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of anti-tumor action of Corynebacterium parvum. I. Potentiated tumor-specific immunity and its therapeutic limitations.
    Dye ES; North RJ; Mills CD
    J Exp Med; 1981 Sep; 154(3):609-20. PubMed ID: 6974214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of cancer using Corynebacterium parvum: similarity of two preparations in four animal tumor models.
    Bartlett GL; Kreider JW; Purnell DM
    Cancer; 1980 Aug; 46(4):685-91. PubMed ID: 7397633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors.
    Fortner GW; Kripke ML
    J Immunol; 1977 Apr; 118(4):1483-7. PubMed ID: 66296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.